Malignant Glioma: MR imaging by using 5-aminolevulinic acid in an animal model

Radiology

Volumn 272, Issue 3, 2014, Pages 720-730

  Cho, Hye Rim ^a   Kim, Dong Hyun ^a   Kim, Daehong ^b   Doble, Philip ^c   Bishop, David ^c   Hare, Dominic ^c   Park, Chul Kee ^a   Moon, Woo Kyung ^a   Han, Moon Hee ^a   Choi, Seung Hong ^a,d  

^a Seoul National University College of Medicine   (South Korea)

^b National Cancer Center   (South Korea)

^c UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^d Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; GLIOMA; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED BALB C; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84906875286     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14131459     Document Type: Article

References (44)

1. Widhalm G, Wolfsberger S, Minchev G, et al. 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement. Cancer 2010;116(6):1545-1552.
2. Watanabe M, Tanaka R, Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 1992;34(6):463-469.
3. Jansen EP, Dewit LG, van Herk M, Bartelink H. Target volumes in radiotherapy for high-grade malignant glioma of the brain. Radiother Oncol 2000;56(2):151-156. (Pubitemid 30601671)
4. Kim JH, Chang KH, Na DG, et al. 3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences. AJNR Am J Neuroradiol 2006;27(7):1412-1418. (Pubitemid 44260119)
5. Arvinda HR, Kesavadas C, Sarma PS, et al. Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging. J Neurooncol 2009;94(1):87-96.
6. Kang Y, Choi SH, Kim YJ, et al. Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging - correlation with tumor grade. Radiology 2011;261(3):882-890.
7. Floeth FW, Pauleit D, Wittsack HJ, et al. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. J Neurosurg 2005;102(2):318-327. (Pubitemid 43194083)
8. Stadlbauer A, Prante O, Nimsky C, et al. Metabolic imaging of cerebral gliomas: spatial correlation of changes in O-(2-18F-fluoroethyl)-L-tyrosine PET and proton magnetic resonance spectroscopic imaging. J Nucl Med 2008;49(5):721-729. (Pubitemid 351717536)
9. Goldman S, Levivier M, Pirotte B, et al. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. J Nucl Med 1997;38(9):1459-1462. (Pubitemid 27386211)
10. Roessler K, Gatterbauer B, Becherer A, et al. Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation. Minim Invasive Neurosurg 2007;50(5):273-280.
11. Sadeghi N, Salmon I, Decaestecker C, et al. Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma. AJNR Am J Neuroradiol 2007;28(3):455-461. (Pubitemid 46481882)
12. Singhal T, Narayanan TK, Jain V, Mukherjee J, Mantil J. 11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas. Mol Imaging Biol 2008;10(1):1-18.
13. Leide-Svegborn S. Radiation exposure of patients and personnel from a PET/CT procedure with 18F-FDG. Radiat Prot Dosimetry 2010;139(1-3):208-213.
14. Stummer W, Stocker S, Novotny A, et al. In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. J Photochem Photobiol B 1998;45(2-3):160-169. (Pubitemid 28550192)
15. Stummer W, Pichlmeier U, Meinel T, et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006;7(5):392-401.
16. Utsuki S, Oka H, Sato S, et al. Possibility of using laser spectroscopy for the intraoperative detection of nonfluorescing brain tumors and the boundaries of brain tumor infiltrates. Technical note. J Neurosurg 2006;104(4):618-620.
17. Ishihara R, Katayama Y, Watanabe T, Yoshino A, Fukushima T, Sakatani K. Quantitative spectroscopic analysis of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence intensity in diffusely infiltrating astrocytomas. Neurol Med Chir (Tokyo) 2007;47(2):53-57; discussion 57.
18. Hefti M, von Campe G, Moschopulos M, Siegner A, Looser H, Landolt H. 5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institutuion. Swiss Med Wkly 2008;138(11-12):180-185.
19. Berlin NI, Neuberger A, Scott JJ. The metabolism of delta -aminolaevulic acid. 1. Normal pathways, studied with the aid of 15N. Biochem J 1956;64(1):80-90.
20. Berlin NI, Neuberger A, Scott JJ. The metabolism of delta -aminolaevulic acid. 2. Normal pathways, studied with the aid of 14C. Biochem J 1956;64(1):90-100.
21. Ryter SW, Tyrrell RM. The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radic Biol Med 2000;28(2):289-309. (Pubitemid 30084022)
22. Chen YH, Yet SF, Perrella MA. Role of heme oxygenase-1 in the regulation of blood pressure and cardiac function. Exp Biol Med (Maywood) 2003;228(5):447-453. (Pubitemid 37203658)
23. Schenck JF. Imaging of brain iron by magnetic resonance: T2 relaxation at different field strengths. J Neurol Sci 1995;134(Suppl):10-18.
24. Schenck JF. Magnetic resonance imaging of brain iron. J Neurol Sci 2003;207(1-2):99-102. (Pubitemid 36287110)
25. Yount GL, Haas-Kogan DA, Vidair CA, Haas M, Dewey WC, Israel MA. Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells. Cancer Res 1996;56(3):500-506. (Pubitemid 26043646)
26. Wu SM, Ren QG, Zhou MO, Wei Y, Chen JY. Photodynamic effects of 5-aminolevulinic acid and its hexylester on several cell lines. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2003;35(7):655-660. (Pubitemid 36980883)
27. Gibbs SL, Chen B, O'Hara JA, Hoopes PJ, Hasan T, Pogue BW. Protoporphyrin IX level correlates with number of mitochondria, but increase in production correlates with tumor cell size. Photochem Photobiol 2006;82(5):1334-1341. (Pubitemid 44702017)
28. Millon SR, Ostrander JH, Yazdanfar S, et al. Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes. J Biomed Opt 2010;15(1):018002.
29. Hefti M, Holenstein F, Albert I, Looser H, Luginbuehl V. Susceptibility to 5-aminolevulinic acid based photodynamic therapy in WHO I meningioma cells corresponds to ferrochelatase activity. Photochem Photobiol 2011;87(1):235-241.
30. Choi SH, Cho HR, Kim HS, et al. Imaging and quantification of metastatic melanoma cells in lymph nodes with a ferritin MR reporter in living mice. NMR Biomed 2012;25(5):737-745.
31. Lear J, Hare D, Adlard P, et al. Improving acquisition times of elemental bio-imaging for quadrupole-based LA-ICP-MS. J Anal At Spectrom 2012;27(1):159-164.
32. Austin C, Fryer F, Lear J, et al. Factors affecting internal standard selection for quantitative elemental bio-imaging of soft tissues by LA-ICP-MS. J Anal At Spectrom 2011;26(7):1494-1501.
33. Hare D, Reedy B, Grimm R, et al. Quantitative elemental bio-imaging of Mn, Fe, Cu and Zn in 6-hydroxydopamine induced Parkinsonism mouse models. Metallomics 2009;1(1):53-58.
34. Hare DJ, George JL, Grimm R, et al. Three-dimensional elemental bio-imaging of Fe, Zn, Cu, Mn and P in a 6-hydroxydopamine lesioned mouse brain. Metallomics 2010;2(11):745-753.
35. Teng L, Nakada M, Zhao SG, et al. Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy. Br J Cancer 2011;104(5):798-807.
36. Roberts DW, Valdés PA, Harris BT, et al. Glioblastoma multiforme treatment with clinical trials for surgical resection (aminolevulinic acid). Neurosurg Clin N Am 2012;23(3):371-377.
37. Norum OJ, Selbo PK, Weyergang A, Giercksky KE, Berg K. Photochemical internalization (PCI) in cancer therapy: from bench towards bedside medicine. J Photochem Photobiol B 2009;96(2):83-92.
38. Rodriguez L, Batlle A, Di Venosa G, et al. Study of the mechanisms of uptake of 5-aminolevulinic acid derivatives by PEPT1 and PEPT2 transporters as a tool to improve photodynamic therapy of tumours. Int J Biochem Cell Biol 2006;38(9):1530-1539. (Pubitemid 44250952)
39. Xiang J, Hu Y, Smith DE, Keep RF. PEPT2-mediated transport of 5-aminolevulinic acid and carnosine in astrocytes. Brain Res 2006;1122(1):18-23. (Pubitemid 44708128)
40. Ewelt C, Floeth FW, Felsberg J, et al. Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence. Clin Neurol Neurosurg 2011;113(7):541-547.
41. Bishop GM, Robinson SR. Quantitative analysis of cell death and ferritin expression in response to cortical iron: implications for hypoxia-ischemia and stroke. Brain Res 2001;907(1-2):175-187. (Pubitemid 32595527)
42. Hirsh M, Konijn AM, Iancu TC. Acquisition, storage and release of iron by cultured human hepatoma cells. J Hepatol 2002;36(1):30-38. (Pubitemid 34234013)
43. Hoepken HH, Korten T, Robinson SR, Dringen R. Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate. J Neurochem 2004;88(5):1194-1202. (Pubitemid 38280687)
44. Peng Q, Warloe T, Berg K, et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997;79(12):2282-2308. (Pubitemid 27251011)